Compliance Rate
Compliance Rate
48.0%
Compliant submissions
48
Incompliant submissions
52
Total trials
100
Your Clinical Trials
Showing 539250 of 542236 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 10/31/26
Due: 10/31/27
Phase: N/A
Priority: Normal
Start: 04/03/23
End: 05/31/26
Due: 05/31/27
Phase: N/A
Priority: Normal
Start: 03/04/25
End: 12/31/32
Due: 12/31/33
Phase: N/A
Priority: Normal
Start: 03/31/07
End: 06/30/08
Due: 06/30/09
Efficacy of Resveratrol Containing Mouthwash in Reducing Halitosis Related Porphyrymonas Gingivalis.
Phase: N/A
Priority: Normal
Start: 01/05/25
End: 11/01/25
Due: 11/01/26
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 04/01/27
Due: 04/01/28
Phase: N/A
Priority: Normal
Start: 04/29/24
End: 09/22/25
Due: 09/22/26
Phase: N/A
Priority: Normal
Start: 02/10/25
End: 07/31/27
Due: 07/31/28
Phase: N/A
Priority: Normal
Start: 03/24/25
End: 08/15/25
Due: 08/15/26
Phase: N/A
Priority: Normal
Start: 02/16/25
End: 04/30/25
Due: 04/30/26
Phase: N/A
Priority: Normal
Start: 10/01/18
End: 08/01/19
Due: 08/01/20
Phase: N/A
Priority: Normal
Start: 10/01/24
End: 01/02/26
Due: 01/02/27
Phase: N/A
Priority: Normal
Start: 09/01/25
End: 05/31/29
Due: 05/31/30
Phase: N/A
Priority: Normal
Start: 05/08/19
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: 04/30/26
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 12/04/24
End: 02/14/25
Due: 02/14/26
Phase: N/A
Priority: Normal
Start: 12/01/24
End: 03/01/25
Due: 03/01/26
Phase: N/A
Priority: Normal
Start: 01/15/25
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 06/30/11
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 03/23/24
End: 10/11/24
Due: 10/11/25
Phase: N/A
Priority: Normal
Start: 02/01/18
End: 09/10/24
Due: 09/10/25
Phase: N/A
Priority: Normal
Start: 04/19/04
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 02/28/21
Due: 02/28/22